GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales ...Middle East

Fortune - News
GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
"We expect another year of profitable growth in 2025, and have further improved our long-term outlook," said CEO Walmsley. Read More

Read More Details
Finally We wish PressBee provided you with enough information of ( GSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales )

Apple Storegoogle play

Also on site :



Latest News